Orlistat

CAS 96829-58-2 11 FDA-DMF suppliersSmall Molecule

Overview

Orlistat is a drug designed to treat obesity by inhibiting the absorption of dietary fats. It works by blocking the enzyme lipase, which is necessary for the digestion of fats.

API suppliers (7)

Suppliers of Orlistat backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
  • Forest Laboratories, Inc.United States1 active DMF
  • CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
  • Biocon LimitedIndia1 active DMF
  • Forest Laboratories, Inc.United States1 active DMF
  • CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China

Chemical identity

IUPAC name
[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
Canonical SMILES
CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
InChIKey
AHLBNYSZXLDEJQ-FWEHEUNISA-N

Therapeutic areas

Obesity

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.